Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Buildings (2016 - 2017)

Immucell (ICCC) has disclosed Buildings for 7 consecutive years, with $5.4 million as the latest value for Q3 2017.

  • For the quarter ending Q3 2017, Buildings rose 7.16% year-over-year to $5.4 million, compared with a TTM value of $5.4 million through Sep 2017, up 7.16%, and an annual FY2016 reading of $5.0 million, up 6.81% over the prior year.
  • Buildings was $5.4 million for Q3 2017 at Immucell, roughly flat from $5.4 million in the prior quarter.
  • Across five years, Buildings topped out at $5.4 million in Q3 2017 and bottomed at $2.8 million in Q1 2013.
  • Average Buildings over 5 years is $4.1 million, with a median of $4.4 million recorded in 2015.
  • The sharpest move saw Buildings grew 1.01% in 2014, then surged 58.8% in 2015.
  • Year by year, Buildings stood at $2.9 million in 2013, then rose by 1.01% to $3.0 million in 2014, then soared by 58.8% to $4.7 million in 2015, then rose by 6.81% to $5.0 million in 2016, then increased by 6.95% to $5.4 million in 2017.
  • Business Quant data shows Buildings for ICCC at $5.4 million in Q3 2017, $5.4 million in Q2 2017, and $5.4 million in Q1 2017.